1-[(2,6-Dichlorophenyl)methyl]-6-oxo-N-[3-(trifluoromethyl)phenyl]-1,6-dihydropyridine-3-carboxamide

Catalog No.: 
ACJOML253
CAS No.: 
339008-63-8
Molecular Formula: 
C20H13Cl2F3N2O2
Molecular Weight: 
441.24
1-[(2,6-Dichlorophenyl)methyl]-6-oxo-N-[3-(trifluoromethyl)phenyl]-1,6-dihydropyridine-3-carboxamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg90%$98.00InquiryInquiry
1g90%$281.00InquiryInquiry
5g90%$1391.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[(2,6-Dichlorophenyl)methyl]-6-oxo-N-[3-(trifluoromethyl)phenyl]-1,6-dihydropyridine-3-carboxamide
IUPAC Name1-(2,6-dichlorobenzyl)-6-oxo-N-(3-(trifluoromethyl)phenyl)-1,6-dihydropyridine-3-carboxamide
MDL No.MFCD00139918
Molecular FormulaC20H13Cl2F3N2O2
Molecular Weight441.24
SMILESO=C(C(C=C1)=CN(CC2=C(Cl)C=CC=C2Cl)C1=O)NC3=CC=CC(C(F)(F)F)=C3
InChI KeyXNSIJFPYTXYWEO-UHFFFAOYSA-N
CAS No.339008-63-8

Synthetic Route by SureRoute

1. ACJOML253 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRAUC529 route compound structure diagram
    ACRAUC5292646-97-1In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJOML253 route product structure diagram
    ACJOML253339008-63-8
Inquiry

2. ACJOML253 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACRAUC529 route compound structure diagram
    ACRAUC5292646-97-1In Stock
  4. Then
  5. ACJOML253 route product structure diagram
    ACJOML253339008-63-8
Inquiry

3. ACJOML253 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJOML253 route product structure diagram
    ACJOML253339008-63-8
Inquiry

Comments (0)